[18F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients

Mammar Hachemi; Olivier Couturier; Laurent Vervueren; Pacôme Fosse; Franck Lacœuille; Thierry Urban; José Hureaux

doi:10.1371/journal.pone.0087629

Loading metrics

Open Access

Peer-reviewed

Research Article

[¹⁸F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients

Mammar Hachemi,

Affiliations LUNAM Université, 49 000, Angers, France, Université d'Angers, CHU Angers, Pôle de Radiologie, Service de Médecine Nucléaire, Angers, France
⨯
Olivier Couturier,

Affiliations LUNAM Université, 49 000, Angers, France, Université d'Angers, CHU Angers, Pôle de Radiologie, Service de Médecine Nucléaire, Angers, France, INSERM UMR_S 1066 Micro et Nanomédecines Biomimétiques, Angers, France
⨯
Laurent Vervueren,

Affiliations LUNAM Université, 49 000, Angers, France, Université d'Angers, CHU Angers, Pôle de Radiologie, Service de Médecine Nucléaire, Angers, France
⨯
Pacôme Fosse,

Affiliations LUNAM Université, 49 000, Angers, France, Université d'Angers, CHU Angers, Pôle de Radiologie, Service de Médecine Nucléaire, Angers, France
⨯
Franck Lacœuille,

Affiliations LUNAM Université, 49 000, Angers, France, Université d'Angers, CHU Angers, Pôle de Radiologie, Service de Médecine Nucléaire, Angers, France, INSERM UMR_S 1066 Micro et Nanomédecines Biomimétiques, Angers, France
⨯
Thierry Urban,

Affiliations LUNAM Université, 49 000, Angers, France, INSERM UMR_S 1066 Micro et Nanomédecines Biomimétiques, Angers, France, Université d'Angers, CHU Angers, Pôle des Spécialités Médicales et Chirurgicales Intégrées, Département de Pneumologie, Angers, France, Université d'Angers, Equipe Pyver, Angers, France
⨯
José Hureaux

* E-mail: JoHureaux@chu-angers.fr

Affiliations LUNAM Université, 49 000, Angers, France, INSERM UMR_S 1066 Micro et Nanomédecines Biomimétiques, Angers, France, Université d'Angers, CHU Angers, Pôle des Spécialités Médicales et Chirurgicales Intégrées, Département de Pneumologie, Angers, France, Université d'Angers, Equipe Pyver, Angers, France
⨯

[¹⁸F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients

Mammar Hachemi,
Olivier Couturier,
Laurent Vervueren,
Pacôme Fosse,
Franck Lacœuille,
Thierry Urban,
José Hureaux

Published: February 5, 2014
https://doi.org/10.1371/journal.pone.0087629

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Computed axial tomography
Is the Subject Area "Computed axial tomography" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Positron emission tomography
Is the Subject Area "Positron emission tomography" applicable to this article?

Thanks for your feedback.
Progressive diseases
Is the Subject Area "Progressive diseases" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.